MicrobeWorld App

appsquarebannerad200x200

Join MicrobeWorld

Subscribe via Email

subscribe

Microbes After Hours

cheese-thumb-small

Click for more "Microbes After Hours" videos

Featured Image

Featured Video

Crowdsourced Microbes Heading to Station

Supporters

ASM House 200X200

ASM Live at ICAAC 2011 Chicago

The Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) is the annual infectious diseases meeting of the American Society for Microbiology. Watch Dr. Jeff Fox, Features Editor for Microbe magazine and host of ASM Live, interview researchers on selected topics of interest from the meeting in Chicago. This webpage will broadcast the daily webcasts being held September 17-20, 2011, at McCormick Place in room W-470B. For more information about ICAAC please visit www.icaac.org. If you are a member of the press visit the ICAAC newsroom to register for the meeting.

In addition, Vincent Racaniello of This Week in Virology and This Week in Microbiology will be broadcasting special editions of both programs live on Saturday, Sept. 17 at 2 p.m., CDT, and Monday, Sept. 19, at 11:45 a.m., CDT, respectively.

Meeting attendees are welcome to attend and watch the live tapings as well as submit questions to the researchers. Tapings will take place in the ASM Press Conference Room of McCormick Center.

All interviews will be broadcast live and archived online at YouTube and here on MicrobeWorld.

[ustream asm-live 630 381] [uschat asm-live 630 381]
(To ask a question please post it in the chat or tweet @microbeworld. You can also use the hash tag #ICAAC)

Schedule

Please note: The following schedule is preliminary and subject to change. Participants and more detail for each conference will be posted soon. All participants are invited, not confirmed. All times are listed as Central Daylight Time. All events take place in room W-470B at McCormick Place in Chicago.

Saturday, September 17

10:00 a.m. CDT – ASM Live Antibiotic-Resistant Bacteria Linked to Seagulls in Miami Beach

Extended spectrum beta-lactamases (ESBL's) are enzymes that enable bacteria to resist multiple antibiotics. In the past few years ESBL-producing enteric bacteria (such as E. coli) have become an increasingly common cause of community acquired infections worldwide. The source of these organisms in the community still remains unclear; however, recent reports link wild animals and water reservoirs to their spread. Researchers will present research showing 8 percent of the enteric bacteria isolated from Miami Beach seagulls were positive for ESBL productionsuggesting these birds play a role in disseminating these bacteria in the environment.

 

11:00 a.m. CDT – ASM Live New Antibiotics in the Pipeline

ICAAC is traditionally a venue for presenting data on new drugs and new drug combinations.Program Committee member Karen Bush will overview of new drugs and clinical trial data being presented this years highlighting the more promising compounds and will discuss the overall state of the antibiotic pipeline.

12:00 Noon, CDT – Press Conference Opening Briefing

Members of the ICAAC Program Committee will give an overview of the ICAAC meeting and discuss sessions of particular interest. Lunch will follow.

  • M. Lindsay Grayson, MD, Austin Health, Melbourne, Australia
  • Craig Rubens, MD, PhD, Seattle Children’s’ Hospital Research Institute, Seattle, WA
  • Laurent Kaiser, M.D., Head of the Laboratory of Virology, University Hospital of Geneva, Geneva, Switzerland

2:00 p.m., CDT - This Week in Virology Live at ICAAC

Participate in a live streaming video episode of This Week in Virology (TWiV), a podcast about viruses. Started in September 2008 by Vincent Racaniello and Dick Despommier, two science Professors at Columbia University Medical Center, the goal of the show is to have an accessible discussion about viruses that anyone can understand and enjoy. At ICAAC in Chicago, Racaniello, co-host Rich Condit and guests will be highlighting and commenting on some of the most exciting virology at the conference. Audience participation is encouraged so please feel free to ask any questions or offer your comments up to discussion.

Guests

  • Trine Tsouderos, Health/Medical Writer, Chicago Tribune
  • Mark Pallansch, Ph.D., Chief of the Enterovirus Section in the National Center for Infectious Diseases at the U.S. Centers for Disease Control

Sunday, September 18

10:00 a.m., CDT –ASM Live Clostridium difficile: Emerging Issues and Treatments

Clostridium difficile infection is an important cause of intestinal disease, primarily affecting hospitalized patients exposed to antibiotics. Infection has been associated with prolonged hospital stays and excess healthcare expenditures.Recent changes in epidemiology of this disease show a rise in community-acquired cases in people outside the hospital settings without traditional risk factors.Participants will discuss this disturbing trend as well as the potential role of animals and the food supply and the status of current vaccine development efforts.

11:00 a.m., CDT –ASM Live New Vaccine Technologies

Needle-based vaccine injections require highly trained health workers and an optimally performing system for effective mass vaccination campaigns. The universal fear of needle sticks is an indicator of the need of convenient and viable alternative modes of delivery. New technologies are making needle-free cutaneous (applied to the skin) vaccines against a variety of diseases a foreseeable reality. Bruce Weniger, Associate Editor of the journal Vaccine will discuss the latest research on cutaneous vaccination.

12:00 noon, CDT –ASM Live The Rise and Control of Gram-Negative Resistance

The launch of new antibiotics in the 1980s led many in the scientific field to believe that fight against bacteria had been won. Since then, at least one group of bacteria known as Gram-negatives (which includes pathogens responsible for hospital-acquired pneumonia and bloodstream infections as well as E. coli and Salmonella have developed a variety of mechanisms that make them multi-drug resistant.The result is that it is now commonplace to encounter gram-negative infections susceptible only to one drug: colistin, an antibiotic all but abandoned in the 1970s and 1980s due to toxic side-effects.Participants will discuss how antibiotic-resistant gram-negatives are on the rise in newly industrialized countries, the threat they pose to the antibiotic revolution of the 20th century and one country's nationwide intervention to control an antibiotic-resistant outbreak in healthcare facilities.

  • David Livermore, PhD, HPA Microbiol. Services Colindale, London, United Kingdom
  • Mitchell Schwaber, MD, Israel Ministry of Health, Tel Aviv, Israel

Monday, September 19

10:00 a.m., CDT –ASM Live Hot Topics in Pediatric Infectious Disease: The Return of Whooping Cough

Despite high infant immunization rates, pertussis infection rates are increasing in many countries and pertussis outbreaks have occurred. Recent control strategies for pertussis have focused on immunizing adolescents and adults with pertussis booster vaccines in an effort to provide herd immunity. Participants will discuss these strategies as well as latebreaking data from the 2010 California outbreak that suggests the booster may be ineffective after 3 years.

11:15 a.m., CDT – ICAAC Live with Vincent Racaniello of This Week in Microbiology

Join a live streaming scientific session at ICAAC hosted by Vincent Racaniello and co-host Michael Schmidt.Audience participation is encouraged so please feel free to ask any questions or offer your comments up to discussion.

Guests

1:30 p.m., CDT –ASM Live Emerging Issues in Infectious Disease

Participants will discuss various emerging issues in the field of infectious disease including drug-resistant malaria; epidemiology and management of cholera in Haiti and whether or not steroids are an effective mechanism for managing bacterial meningitis.

 

Comments (0)

Collections (1)

American Society for Microbiology
2012 1752 N Street, N.W. • Washington, DC 20036-2904 • (202) 737-3600
American Society For Microbiology © 2014   |   Privacy Policy   |   Terms of Use